Skip to main content
  • Interstitial lung diseases and lung in systemic diseases
  • Open access
  • Published:

Factors predicting pulmonary hypertension in idiopathic pulmonary fibrosis patients

Abstract

Context

Pulmonary hypertension (PH) is a common complication of idiopathic pulmonary fibrosis (IPF) and an important pathophysiologic mechanism of exercise intolerance and poor quality of life in these patients.

Aims

The aims of this study were to assess predictors of PH in IPF from both resting pulmonary function test (PFT) and cardiopulmonary exercise testing (CPET) parameters and to establish cut-off values from resting PFT and CPET parameters for the prediction of PH.

Settings and design

This was a randomized, double-blind, and prospective study.

Patients and methods

Thirty-five patients with stable IPF were assessed in terms of resting pulmonary functions, arterial blood gases (ABG), echocardiography, and incremental CPET. Patients were classified into a PH group and a non-pulmonary-hypertension group.

Statistical analysis

Both groups were compared in terms of resting PFT and CPET parameters. A receiver operating characteristic curve was constructed to establish cut-off values for the prediction of PH.

Results

PH was observed in 13 (37.14%) patients. There were no significant differences between both groups in age and sex. forced vital capacity (FVC)%, forced expiratory volume in one second (FEV1)%, inspiratory capacity, resting and exercise partial arterial oxygen tension (PaO2) and arterial oxygen saturation (SaO2), and oxygen consumption (VO2%) were significantly reduced in the PH group, whereas the dyspnea score, resting and exercise PaCO2, respiratory frequency, and minute ventilation were significantly increased in the PH group. The receiver operating characteristic curve showed that resting SaO2 of 92.9% or less and exercise SaO2 of 87% or less had sensitivity of 84.6, and 100%, and specificity of 90.9 and 81.8%, respectively.

Conclusion

Marked deterioration in resting PFT, exercise parameters, and SaO2 can predict PH in IPF patients.

References

  1. Farkas L, Gauldie J, Voelkel NF, Kolb M. Pulmonary hypertension and idiopathic pulmonary fibrosis a tale of angiogenesis, apoptosis, and growth factors. Am J Respir Cell Mol Biol 2011; 45:1–15.

    Article  CAS  Google Scholar 

  2. D’Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115:343–349.

    Article  Google Scholar 

  3. Nathan SD, Shlobin OA, Ahmad S, Urbanek S, Barnett SD. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 2007; 131:657–663.

    Article  Google Scholar 

  4. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006; 129:746–752.

    Article  Google Scholar 

  5. Kimura M, Taniguchi H, Kondoh Y, Kimura T, Kataoka K. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis. Respiration 2013; 85:456–463.

    Article  Google Scholar 

  6. Nadrous HF, Pellikka PA, Krowka MJ, et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005; 128:2393–2399.

    Article  Google Scholar 

  7. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown K, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183:788–824.

    Article  Google Scholar 

  8. Mador MJ, Rodis A, Magalang UJ. Reproducibility of Borg scale measurements of dyspnea during exercise in patients with COPD. Chest 1995; 107:1590–1597.

    Article  CAS  Google Scholar 

  9. Gupta NK, Agrawal RK, Srivastav AB, Ved ML. Echocardiographic evaluation of heart in chronic obstructive pulmonary disease patients and its co-relation with the severity of disease. Lung India 2011; 28:105–109.

    Article  CAS  Google Scholar 

  10. Strange C, Highland KB. Pulmonary hypertension in interstitial lung disease. Curr Opin Pulm Med 2005; 11:452–455.

    Article  Google Scholar 

  11. Hamada K, Nagai S, Tanaka S, et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007; 131:650–656.

    Article  Google Scholar 

  12. Agarwal R, Gupta D, Verma JS, Aggarwal AN, Jindal SK. Noninvasive estimation of clinically asymptomatic pulmonary hypertension in idiopathic pulmonary fibrosis. Indian J Chest Dis Allied Sci 2005; 47:267–271.

    CAS  Google Scholar 

  13. Shorr AF, Wainright JL, Cors CS, Lettieri CJ, Nathan SD. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 2007; 30:715–721.

    Article  CAS  Google Scholar 

  14. Gläser S, Noga O, Koch B, Opitz CF, Schmidt B, Temmesfeld B, et al. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir Med 2009; 1031:317–324.

    Article  Google Scholar 

  15. Javier S, Sicilian L. Lung function, breathing pattern, and gas exchange in interstitial lung disease. Thorax 1992; 47:93–97.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Samiaa H. Sadek MD.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sadek, S.H., Kasem, S.M. Factors predicting pulmonary hypertension in idiopathic pulmonary fibrosis patients. Egypt J Bronchol 9, 55–58 (2015). https://doi.org/10.4103/1687-8426.153607

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1687-8426.153607

Keywords